BioSpace News Archive

FDA

FDA Moves to Restrict Industry Influence on Advisory Committees

Industry representatives will still be allowed at these meetings, but they will no longer have a spot on the advisory committee.

April 18, 2025

·

2 min read

·

Tristan Manalac

Reduce risk level or decrease stress anxiety meter, lower danger indicator or scale, reduce from red alert meter to be green chart concept, businesswoman pull meter to reduce risk or stress level.

Business

Elevation Mulls Strategic Alternatives, Including Closure, Amid Activist Pressure

BML Capital Management, an activist investor that owns 9.9% of Elevation’s shares, is urging the company to wind down operations given “the current state of the public equity market.”

April 18, 2025

·

2 min read

·

Tristan Manalac

Two arrow signs representing the new way and old way approach to business

Editorial

Here Today, Gone Tomorrow: Trump’s Policies Give Biopharma Whiplash

Like they say about the weather in Iceland, if you don’t like an action taken by the new administration, wait five minutes; it’ll probably change. The markets, it seems, don’t react kindly to that kind of policymaking.

April 18, 2025

·

4 min read

·

Jef Akst

Halftone hands shake coins out of paper money. Modern collage. Concept of inflation, bankruptcy, poverty. Financial difficulties

Deals

Unusual New Fund Launches to Unlock Some $30B of Capital ‘Trapped’ in Public Biotechs

Alis Biosciences’ plan is a familiar tactic in the private equity world, but the firm will instead be listed on the public markets “in due course.”

April 18, 2025

·

3 min read

·

Annalee Armstrong

Rug pull crypto, scam coin, trading problem, investment risk in unstable and uncertainty stock market concepts. Unknown people pull carpet and make businesspeople who standing on money falling down.

FDA

FDA’s User Fee Negotiation Teams Gutted by Layoffs: Reuters

Losing the FDA’s senior negotiators would slow the renewal of the user fee programs “considerably,” according to policy and regulatory expert Steven Grossman.

April 18, 2025

·

2 min read

·

Tristan Manalac

Press Releases

Proof-of-Concept Data for Rare Disease Indications MVID and SBS-IF for Jaguar Health’s Crofelemer to be Presented at April 2025 ELITE PED-GI Congress

April 18, 2025

·

7 min read

Press Releases

Caliway Selected to Present CBL-514 Phase 2 Study Results for Dercum’s Disease at World Orphan Drug Congress USA 2025